Penile Prosthesis Use Decreasing in Erectile Dysfunction

This article originally appeared here.
Share this content:
Penile Prosthesis Use Decreasing in Erectile Dysfunction
Penile Prosthesis Use Decreasing in Erectile Dysfunction

TUESDAY, June 30, 2015 (HealthDay News) -- Use of penile prosthesis (PP) insertion has decreased for erectile dysfunction (ED), according to a study published online June 22 in the Journal of Sexual Medicine.

Daniel J. Lee, M.D., from the Weill Cornell Medical College in New York City, and colleagues assessed use of PP in an analysis of the 5 percent Medicare Public Use Files from 2001 to 2010. Factors associated with PP placement, type of PP utilized, and revision were identified in regression analysis.

The researchers found that 3 percent of the 1,763,260 men diagnosed with ED underwent PP insertion. There was a decrease noted in utilization of PP for ED, from 4.6 percent in 2002 to 2.3 percent in 2010 (P = 0.01). The decrease was significant across all demographic factors, including age, ethnicity, and geographic location. The likelihood of utilizing PP insertion for ED was increased for men aged 65 to 74 years, those from the U.S. South and West, and those with Charlson comorbidity scores of >1 (P < 0.01). Compared with Caucasian men, African-American men were more likely to have a semi-rigid versus a multicomponent inflatable PP, and to undergo a revision or removal of PP (P < 0.01).

"The surgical management of ED with PP implantation changed significantly between 2001 and 2010," the authors write.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »